NeueHealth (NYSE:NEUE) Posts Quarterly Earnings Results, Misses Estimates By $5.12 EPS

NeueHealth (NYSE:NEUE) posted its quarterly earnings data on Thursday. The company reported ($7.41) earnings per share for the quarter, missing the consensus estimate of ($2.29) by ($5.12), Zacks reports. NeueHealth had a negative return on equity of 6.40% and a negative net margin of 36.28%. The business had revenue of $232.64 million for the quarter, compared to analyst estimates of $261.80 million.

NeueHealth Stock Up 4.1 %

Shares of NEUE opened at $5.49 on Friday. NeueHealth has a 12-month low of $3.79 and a 12-month high of $7.66. The firm has a market capitalization of $45.45 million, a price-to-earnings ratio of -0.11 and a beta of 0.56. The stock’s 50-day moving average price is $7.03 and its 200 day moving average price is $6.00.

Wall Street Analysts Forecast Growth

Separately, Royal Bank of Canada lowered their price target on NeueHealth from $8.00 to $7.00 and set a “sector perform” rating on the stock in a research note on Monday, December 9th.

Insider Activity at NeueHealth

In other news, CFO Jay Matushak sold 4,970 shares of the company’s stock in a transaction that occurred on Monday, January 6th. The stock was sold at an average price of $7.33, for a total value of $36,430.10. Following the sale, the chief financial officer now directly owns 17,747 shares in the company, valued at approximately $130,085.51. This represents a 21.88 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. Also, CEO George Lawrence Mikan III sold 31,798 shares of the company’s stock in a transaction that occurred on Monday, January 6th. The shares were sold at an average price of $7.33, for a total value of $233,079.34. Following the completion of the sale, the chief executive officer now owns 146,539 shares in the company, valued at approximately $1,074,130.87. This represents a 17.83 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 110,033 shares of company stock worth $774,560 over the last three months. Company insiders own 64.30% of the company’s stock.

NeueHealth Company Profile

NeueHealth, Inc, a healthcare company, provides various healthcare services for health consumers, providers, and payors in the United States. It operates through two segments: NeueCare and NeueSolutions. The NeueCare segment delivers healthcare services to ACA marketplace, medicare, and medicaid through owned and affiliated clinics.